New technique removes inoperable abdominal tumors

Share this article:
New Technique Removes Inoperable Abdominal Tumors
New Technique Removes Inoperable Abdominal Tumors

(HealthDay News) -- Multivisceral ex vivo surgery can successfully remove invasive abdominal tumors previously deemed unresectable due to location and vascular involvement, according to a case report published in the May issue of the American Journal of Transplantation.

Tomoaki Kato, M.D., of the Columbia University Medical Center in New York City, and colleagues describe three cases of multivisceral ex vivo surgical procedures in patients with abdominal tumors involving both roots of the celiac and superior mesenteric artery, which are generally considered to be unresectable. Procedures involved temporary removal of the entire abdominal viscera, vascular reconstruction, tumor resection outside the body, and autotransplantation of excised organs.

In all three cases, the researchers found that a complete tumor resection was achieved with negative margins. After 17-, 27-, and 38-month follow-up, all patients survived with no tumor recurrence. Diarrhea, sphincter of Oddi dysfunction, and arterial stenosis were postoperative complications, all of which responded to directed treatments.

"Multivisceral ex vivo surgery applying techniques of deceased donor multivisceral transplantation is feasible in achieving local control of otherwise unresectable abdominal tumors," the authors write. "This surgery is best suitable for locally invasive tumors unresectable because of location and vascular involvement."

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Daily Oncology News

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Risk of Diabetes Up in Hodgkin's Lymphoma Survivors

Risk of Diabetes Up in Hodgkin's Lymphoma Survivors

Para-aortic radiation with 36 Gy linked to increased diabetes mellitus risk

United Nations' World Health Organization (WHO) recommends indoor e-cigarettes ban

United Nations' World Health Organization (WHO) recommends indoor ...

WHO recommendation came a day after similar calls for e-cigarette regulation by American Heart Association.

American Heart Association (AHA) issues guidelines for electronic cigarette use

American Heart Association (AHA) issues guidelines for electronic ...

AHA supports inclusion of e-cigarettes in state and federal laws prohibiting sale and marketing to minors.